Skip to main content

Table 2 Initial laboratory findings between the polymerase chain reaction-negative conversion group and non-negative conversion group within 28 days (N = 136)

From: Pneumonia-targeted lopinavir/ritonavir-based treatment for patients with COVID-19: an early-period retrospective single center observational study

Variables, median (IQR)

Negative conversion

(N = 53)

Non-negative conversion

(N = 83)

P value

White blood cells, 109/L

5.60 (4.20–7.35)

5.20 (4.45–6.50)

0.556

Lymphocyte, %

30.80 (24.25–36.90)

27.30 (19.60–34.10)

0.160

Neutrophil to lymphocyte ratio

1.87 (1.41–2.76)

2.17 (1.53–3.25)

0.258

C-reactive protein, mg/dL

0.33 (0.11–1.56)

0.17 (0.09–0.60)

0.180

Procalcitonin, mg/dL

0.04 (0.02–0.05)

0.04 (0.03–0.05)

0.244

Lactate dehydrogenase, U/L

244 (214–313)

240 (206–283)

0.246

Ferritin, μg/L

205.91 (120.61–441.07)

145.84 (71.04–284.62)

0.118